Lv3
240 积分 2025-06-09 加入
Both binding and blocking antibodies correlate with disease severity in myasthenia gravis
16天前
已完结
Acetylcholine receptor blocking antibodies in myasthenia gravis: reevaluating their role in disease severity and mechanisms
16天前
已完结
AChR-blocking antibodies and complement system dynamics: evaluating their interplay and clinical implications in myasthenia gravis
17天前
已完结
Mechanisms of acetylcholine receptor loss in myasthenia gravis
17天前
已关闭
The changing landscape of autoantibody testing in myasthenia gravis in the setting of novel drug treatments
17天前
已完结
Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets
17天前
已完结
Association of blocking acetylcholine receptor antibodies with clinical subtypes and disease severity in myasthenia gravis
17天前
已完结
Response of refractory residual ocular symptoms to efgartigimod in generalized myasthenia gravis: A real-world case series
4个月前
已完结
Association of blocking acetylcholine receptor antibodies with clinical subtypes and disease severity in myasthenia gravis
4个月前
已完结
抗磷脂综合征合并颈内动脉闭塞患者药物涂层球囊扩张血管成形术一例
7个月前
已完结
皖公网安备34019202002308
